Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis ; volume:13 ; number:1 ; day:25 ; month:9 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (25.9.2023), 1-8, 12.2023
- Urheber
-
Tanaka, Akihito
Sasaki, Sho
Noma, Hisashi
Wang, Jui
Onishi, Yoshihiro
Inaguma, Daijo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-43177-9
- URN
-
urn:nbn:de:101:1-2024020515234447185424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tanaka, Akihito
- Sasaki, Sho
- Noma, Hisashi
- Wang, Jui
- Onishi, Yoshihiro
- Inaguma, Daijo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality